Literature DB >> 12373469

Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use.

Onnen Moerer1, Alexandra Schmid, Michael Hofmann, Anja Herklotz, Konrad Reinhart, Karl Werdan, Heinz Schneider, Hilmar Burchardi.   

Abstract

OBJECTIVE: To determine the direct costs of severe sepsis patients in German intensive care units (ICUs).
DESIGN: Retrospective electronic data analysis.
SETTING: Three adult intensive care units (surgical/medical) in three university hospitals in Germany. PATIENTS: 385 patients identified by standard definitions as suffering from severe sepsis. MEASUREMENTS AND
RESULTS: A bottom-up approach was used to determine the direct ICU cost on actual resource use (medication, laboratory tests, microbiological analysis, disposables, and clinical procedures) for patients with severe sepsis. To determine the total direct costs, center-specific personnel and basic bed ("hotel") costs were added to total resources consumed. Average hospital mortality of severely septic patients was 42.6%. Mean ICU length of stay (LOS) was 16.6 days. Survivors stayed on average 4 days longer than nonsurvivors. The mean direct ICU costs of care were 23,297+/-18,631 euros per patient and 1,318 euros per day. In comparison, average daily charges being paid for an ICU patient by the health care system in Germany are 851 euros (based on official statistics). Nonsurvivors were more expensive than survivors in total direct costs (25,446 vs. 21,984 euros) and in per day direct cost (1,649 vs. 1,162 euros). Medication makes up the largest part of the direct costs, followed by expenses for personnel. CONCLUSIONS. Patients with severe sepsis have a high ICU mortality rate and long ICU LOS and are substantially expensive to treat. Nonsurviving septic patients are more costly than survivors despite shorter ICU LOS. This is due to higher medication costs indicating increased efforts to keep patients alive.

Entities:  

Mesh:

Year:  2002        PMID: 12373469     DOI: 10.1007/s00134-002-1429-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

Review 1.  [Progress in therapy of infection].

Authors:  U Müller-Werdan; M Buerke; K Werdan
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

2.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

Review 3.  [Urosepsis and treatment].

Authors:  F M E Wagenlehner; C Lichtenstern; M A Weigand; W Weidner
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

Review 4.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

Review 5.  [The role of endothelial progenitor cells in sepsis].

Authors:  G C Beck; N Rafat; B Yard; C Hanusch
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

Review 6.  [Sepsis. Update on pathophysiology, diagnostics and therapy].

Authors:  M Bauer; F Brunkhorst; T Welte; H Gerlach; K Reinhart
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

7.  Sepsis in Buraidah Central Hospital, Qassim, Kingdom of Saudi Arabia.

Authors:  Gasim I Gasim; Imad R Musa; Taha Yassin; Hani A Al Shobaili; Ishag Adam
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

8.  [Cost of intensive care in a German hospital: cost-unit accounting based on the InEK matrix].

Authors:  J Martin; C Neurohr; M Bauer; M Weiss; A Schleppers
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

Review 9.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial.

Authors:  Brent C Opmeer; Kimberly R Boer; Oddeke van Ruler; Johannes B Reitsma; Hein G Gooszen; Peter W de Graaf; Bas Lamme; Michael F Gerhards; E Philip Steller; Cecilia M Mahler; Huug Obertop; Dirk J Gouma; Patrick Mm Bossuyt; Corianne Ajm de Borgie; Marja A Boermeester
Journal:  Crit Care       Date:  2010-05-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.